Correlation Between Viridian Therapeutics and Sanara Medtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Sanara Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Sanara Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Sanara Medtech, you can compare the effects of market volatilities on Viridian Therapeutics and Sanara Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Sanara Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Sanara Medtech.

Diversification Opportunities for Viridian Therapeutics and Sanara Medtech

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viridian and Sanara is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Sanara Medtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanara Medtech and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Sanara Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanara Medtech has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Sanara Medtech go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Sanara Medtech

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.3 times more return on investment than Sanara Medtech. However, Viridian Therapeutics is 1.3 times more volatile than Sanara Medtech. It trades about 0.12 of its potential returns per unit of risk. Sanara Medtech is currently generating about 0.07 per unit of risk. If you would invest  1,200  in Viridian Therapeutics on August 31, 2024 and sell it today you would earn a total of  955.00  from holding Viridian Therapeutics or generate 79.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Sanara Medtech

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Viridian Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Sanara Medtech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sanara Medtech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Sanara Medtech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Viridian Therapeutics and Sanara Medtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Sanara Medtech

The main advantage of trading using opposite Viridian Therapeutics and Sanara Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Sanara Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanara Medtech will offset losses from the drop in Sanara Medtech's long position.
The idea behind Viridian Therapeutics and Sanara Medtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities